参考文献

1.郭定九易凡,译.皮肤免疫病理学.1980年,长沙

2.SerreG, Viocent C , et al. Natural IgM and Igg autoantibodies to epidermal keratinsin normal human sera:I ELISA titration immunofluorecence study. J Invest Dermatol, 1987, 88:21~27

3.王刚,等.抗角蛋白自身抗体的研究进展.国外医学(皮肤病学分册),1982,18(2):74

4.聂祝湘,等.天疱疮抗体及其临床意义.临床皮肤病科杂志,1991,20(6):317~319

5. 聂祝湘,等.天疱疮治疗的某些进展.国外医学(皮肤病学分册),1991, 17(5):265~268

6.ThompsonC, et al. Expression of blood group antigen by cultured human epidermal cells.J Invest Dermatol, 1986, 86:394~398

7.jANdBos. sis . keratinocyte p 75, CTC Press, Inc . Florida AM, 1989

8. 白兆霞,等.尖锐湿疣病损的免疫组化研究.中华皮肤科杂志,1992, 25:247

9.赵玉铭,等.HLA抗原在正常皮肤中的分布.中华皮肤科杂志,1991, 23(6):402

10. VanLis JM , et al. Cin- Areaction with plasma membrane in human epidermsi. Am JClin Pathol, 1983, 779(1):143~4

11.Hashimoto K, etal. A Lectin – binding glyciprotein of Mr 135000 associated withbasal keratinocyte in pig epidermis. Biochem J, 1986,237(2):405~414

12.唐书谦,等.不同底物对大疱性皮肤病间接免疫荧光的评价评价.中华皮肤科杂志,1988,22(1):36

13. 刘荣卿,等.天疱疮及大疱性类天疱疮外观正常皮肤的免疫荧光检查.中华皮肤科杂志,1987,20:138

14. 聂祝湘,等.止血芳酸治疗天疱疮的实验观察.中华皮肤科杂志,1992, 25(4):256~258

15. WickMR and Scheithauer. Primary neuroendocrine carcinoma of the skin. In :Pathology oof Unsual MalignantCutaneous Tumors. Wick MR ed. Ne W Yorh. Marcel Dekker INC, 1985. 107

16.Narisawa Y, Hashimoto K, Bayless T, et al. Cytokeratin polypeptide Profile ofmerkel cells in human fetal and adult skin:difference of expression of cytokeratins inepidermal and dermal merkle cells. j Invest Dermatol, 1992, 98:171

17.Narisawa Y , Hashimoto K, Nihei Y, et al. Biological significance of dermalmerkle cells in development of cutaneous nerves in human fetal skin. J HistchemCytochem, 1992;40:65

18. 刘荣卿唐书谦徐洁芳,等.天疱疮及大疱性类天疱疮外观正常皮肤的免疫荧光检查.中华皮肤科杂志,1987,20(3):138~140

19. 刁庆春刘荣卿唐书谦.天疱疮、类天疱疮自身抗体检测的临床意义。中华皮肤科杂志,1988,21(5):283

20.朱学骏niimi YJ Bystryn JC.大疱性类天疱疮抗原分子异质性。中华皮肤科杂志,1990,23:291~293

21.靳培英是元甫。疱疹样皮炎在我国的发病情况及其诊断标准的商榷.中华皮肤科杂志,1991,24(4):232~235

22.Prost G, et al. Diagnosis of adultlinear IgA dermatosis by immuno ╟ electromicroscopy in 16 patients withlinear IgA deposits. J Invest Dermatol,1989, 92(1):39~45

23.wojnarowska F, Marsden RA, Bhogal B, et al. Chronic bullous disease ofchildhood, childhood cicatricial pemphigoif, and linear Iga disease of adults.A comparative study demonsrating clinical and immunopathologic overlap. J AmAcad Dermatol, 1988, 19(5):792~805

24. 朱学骏Niimi YJ Bystryn JC.抗基底膜带抗体阳性血清患者中获得性大疱性表皮松解症的发生率.临床皮肤科杂志,1990,19(4):170~173

25.Akutsu Y and Jimbow K. Immunoelectron microscopic demonstration of humanmelanosome associated antigens (HMSA) on melanoma cells:Comparison with tyrosinasedistribution. J Invest Dermatol, 1988, 90:179

26.NakanishiT and Hashimoto K. The differential reactive of benign and malignantnevomelanecytic lesions with mouse monoclonal antibody TNKH1. Cancer, 1987, 50:1340

27. ImamA, Mitchell MS, Modlin RL, et al. Human monoclonal antibodies that distinguishcutaneous malignant melanomas form benign nevi in fixed Tissue sections. JInvest Dermatol, 1986, 86:145

28. GownAM, Vogel AM, Hoak M , et al. Monoclonan antibodies specific for melanocytictumors distinguish subpopulations of melanocytes. Am j Pathol, 1986, 123:195

29.Schaumburg - Lever G, Metzler G, Kaiserling E.Ultrastructural localization ofHMB –45 binding sites. J Cutan Pathol, 1991,18:432

30. 天高文叶庆佾刘荣卿.异常黑素小体在恶性黑素瘤诊断中的意义.第三军医大学学报,1992,14(4):323

31.Furukawa K and Lloyd KO. Gangliosides in melanoma. IN:Human Melanoma. From Basicresearch to dinical application. Ferrone S ed. New York Springer –Verlag, 1990:15

32.Taniguchi M, Kuwabara I, Harada Y, et al. Cross ╟ species melanoma antigen. 1990.

33.Werkmeister JA, Triglia T, Mackay IR, et al. Fluctuations in the expression ofa glyolipid antigen assocted with differentiation of melanoma cells monitoredby a monoclonal antibody , Leo Me13. Cancer Res, 1987,47:225

34. 田芳金伯泉黄传书,等.抗人黑素瘤单克隆抗体免疫组化的研究.单克隆抗体通迅,1991,7:21

35. EstinCD, Plowman CD, Rose TM, et al. Characterization of P[XB]97[/XB], a humanmelanoma -associated antigen, and development of a recombinant vaccien formelanoma. In:Human Melanoma. From basic research to clinical application . FerroneSed. New York. Springer –Verlag, 1990.87

36.高天文刘荣卿叶庆佾.无色素性恶性黑素瘤免疫组化诊断研究.中华皮肤科杂志,1992, 25:222

37. 刘荣卿高天文.无色素性恶性黑素瘤的诊断探讨.实用肿瘤杂志,1992,7:152

38.NagataH, Ueki H, Moriguchi T, et al. Fibronectin,localization in normal human skin,granulation tissue, hypertropic scar, maure scar, progressive systemicsclerotic skin, and other fibrosing dermatoses. Arch Dermatol, 1985, 121(8):995~999

39.Linares HA. Protroglycan – lymphocyte association in the development ofhypertrophic scars. Burns, 1990, 16(1):21~24

40.Branchet MC, Boisnic S, Bletry O, et al. Exxpression of HLA class II antigensonskin fibroblasts in scleroderma. Br J Dermatol, 1992,12(5):431~435

41.CastagnoliC, Stella M, Magliacani G, et al. Anomalous expression of HLA class IImolecules on kerattinocytes and fibroblasts in hypdrtropgicscars consequent tothermal injury. Clin Exp Immunol, 1990, 82(2):350~354

42.Needleman BW, Increased expression of intercellular adhesion molecule 1 on thefibroblasts of scleroderma patientl. Arthritis Rheum,1990, 33(12):1847~1851

43.Skalli U, Schurch W, Seemayer T, et al. Myofibrollasts from diverse pathologicsetting are heterogeneous in their content of actin isoforms and intermediatefilament proteins. Lab Invest, 1989, 60(2):275

44.Sollberg S, Peltonen J, Uitto J, et al. Elevated expressoin of β[XB]2[/XB]and β[XB]2[/XB]integrins, intercellularadhesion molecule 1, and endothelial leukocyte adhesion molecule 1 in the skinof patients with sysytemic sclerosis of recent onset .Arthritis Rheum, 1992;35(3):290~298

45. GayS, Jones RE, Huang GQ, et al. Immunohistologic demonstration of platelet -derives growth factor and sis – oncogene expression in scleroderma. J InvestDermatol, 1989, 92(2):301~303

46.Klareskog L, Gustafsson R, Scheynius A, et al. Increased expression of platelet– derives growth factor type B receptors in the skin of patients with systemicsclerosis. Arthritis Rheum, 1990, 94(2):197~203

47.Gruschwitz M, Muller PU, Sepp N, et al. Transcription and expression oftransforming growth factor type beta in the skin of progressive systemicsclerosis:amediator of fibrosis? J Invest Dermatol, 1990, 94(2):197~203

48.Peltonen J, Hsiao LL, Jaakkola S, et al. Activation of collagengene expressionin keloids :colocalization of type I and IV collagen and transforming growth factor–β[XB]1[/XB]mRNA.J Invest Dermatol, 1991;97(2):240~248

49.TraniAMA, Gruber BL, Kaufman LD, et al. Mast cell changes in scleroderma. ArthritisRheum, 1992;35(8):933~939

50.Hashimoto K, et al. Anti – keratin monoclonal antibodies :production, specificities andapplications. J Cutan Pathol, 1983;6(10):529~539

51.KallioinenM, et al. β-2-microglobulin in benign and malignant adnexal skin tumors andmetastasizing basocellular carcinoma. J Cutan Pathol, 1984;1(11):27~34

52.Penney NS. Immunohistochemistry of adnexal neoplasms. j Cutan Pathol , 1984;(11):357~364

53.SwansonPE, et al. Eccrine sweat gland carcarcinoma:an histologic and immunohistochemical studyof 32 cases. J Cutan Pathol,1987,2(4):65~86

54. NodaY, et al. Immunohistochemical study of carbonic anhydrase in mixed tumors andadenomas of sweat and sebaceous glands. J Cutan Pathol, 1987;5(14):285~290

55.NodaY,et al. Immunohistochemical localization by monoclonal antibody of humanepidermal growth factor in mixed tumors of the skin. J Cutan Pathol, 1987;6(14):337~342

56. ZukJA, et al. Immunohistochemistry staining patterns of sweat glands and theirneoplasms using two nomoclonal antibodies to keratieos. j Cutan Pathol, 1988;1(15):8~17

57.MazoujianG, et al. Immunohistochemistry of gross disease fluid protein (GCDFP-15) in 65benign sweat gland tumors of the skin. Am j Dermatopathol, 1988, 1(10):28~35

58. WoodWS, et al. Mammary Paget’s disease and intraductal carcinoma :histologic, histologic,histochemical and immunocytochemical comparison. Am j Dermatopathol, 1988,10(3):188

59.Mihara M. Chondroid syringoma associated with hidrocystoma – like changes :possible differentiation intoeccring gland:a histologic. immunohistochemical and electron microscopic study. JCutan Pathol, 1989, 5(16):281~286

60.Penneys NS, et al. Immunohistochemistry demonstration of ferritin in sweatgland and sweat gland neoplasms. J Cutan Pathol, 1990, 1(17):32~36

61. UranoY, et al. Immunohistochemistry demonstration of petidylarginine deiminase inhuman sweat glands. Am J Dermatopathol, 1990;12(3):249~255

62.Mazoujian G. Immunohistochemistry of GCDFP –24 and zinic alpha2 glycoprotein inbenign sweat gland tumors. Am J Dermatopathol,1990, 12(5):452~457